LOXL2 and prostate carcinoma: Nguyen et al. pointed out that CAF-derived LOXL2 produced a highly aligned ECM by autocrine and paracrine signaling in tumor microenvironment in prostate cancer, thereby promoting the migration of CAF and neighbored prostate tumor cells52.